Now Putin will also get Russian Sputnik V vaccine vaccine, formal approval given

How Russia’s Sputnik V Vaccine Works

Russia’s vaccine is based on common cold-causing adenovirus. This vaccine has been created in an artificial way. It mimics the structural proteins found in the coronavirus SARS-CoV-2, which produces exactly the same immune response in the body as a result of a coronavirus infection. That is, in one way, the human body responds in the same way as the coronavirus infection, but it does not have the fatal consequences of COVID-19. Clinical trials began on 18 June at Moscow’s Seyshenov University. In a study done on 38 people, this vaccine has been found safe. Immunity was also found against viruses in all volunteers.

Russia starts giving Sputnik-V corona vaccine, clinics lying vacant in their own country

Russia has also faced criticism for not completing all phases of experimental testing. Experts from within the country and abroad also warned against widespread use of the vaccine till its completion. At the same time, the administration, ignoring suggestions, started giving vaccines to at-risk groups, including health workers working on the advance fronts. Alexander Gintzberg, head of the Gamalaya Institute that developed the vaccine, said last week that more than one and a half million people in Russia had been given vaccine doses.

Vaccine manufacturers said the study showed that the sputum vaccine was 91 percent effective. This result was derived from a study conducted on about 23,000 participants, while Western countries included more people, people of different backgrounds, ages, in the test. Levada Center, an independent survey organization in Russia, conducted an opinion poll in October, with 59 percent saying they would not like to take the vaccine despite being offered it. Talking to some health workers and teachers led to the fact that they did not want to take the vaccine due to not being tested properly.

Russia

is also facing criticism for not suspecting the Russian Corona vaccine for not completing all phases of the experimental trial. Experts at home and abroad have also cautioned against widespread use of the Russian vaccine till its completion. At the same time, Russia has continued to vaccinate at-risk groups, including health workers working on the front fronts, ignoring suggestions.